Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 532

1.

Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.

Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois PA, Farley J, Malee K; PACTG 219C Team.

Pediatrics. 2006 Dec;118(6):e1745-57. Epub 2006 Nov 13.

PMID:
17101712
2.

Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.

Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S, Robbins GK; Protocol Teams of ACTG 384, ACTG 731 and A5031s.

AIDS Behav. 2004 Jun;8(2):141-50.

PMID:
15187476
3.

Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count.

Farley JJ, Montepiedra G, Storm D, Sirois PA, Malee K, Garvie P, Kammerer B, Naar-King S, Nichols S; PACTG P1042S Team.

J Dev Behav Pediatr. 2008 Oct;29(5):377-84. doi: 10.1097/DBP.0b013e3181856d22.

PMID:
18714204
4.

The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children.

Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ.

Pediatr Infect Dis J. 2004 Nov;23(11):1035-41.

PMID:
15545859
5.

Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.

Storm DS, Boland MG, Gortmaker SL, He Y, Skurnick J, Howland L, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Study Team.

Pediatrics. 2005 Feb;115(2):e173-82. Epub 2005 Jan 3.

PMID:
15629958
6.

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, Morse EV, Krogstad PA, Nachman S; Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team.

Pediatrics. 2002 Apr;109(4):e61.

PMID:
11927734
7.

Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.

Glikman D, Walsh L, Valkenburg J, Mangat PD, Marcinak JF.

Pediatrics. 2007 May;119(5):e1142-8. Epub 2007 Apr 23.

PMID:
17452493
8.
9.

Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370.

Ickovics JR, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA, Kuritzkes DR; Adult AIDS Clinical Trials Group 370 Protocol Team.

Antivir Ther. 2002 Sep;7(3):185-93.

PMID:
12487386
10.

Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.

Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR; Adolescent Medicine HIV/AIDS Research Network.

Arch Pediatr Adolesc Med. 2005 Aug;159(8):764-70.

PMID:
16061785
11.

HIV treatment-related knowledge and self-efficacy among caregivers of HIV-infected children.

Nicholson O, Mellins C, Dolezal C, Brackis-Cott E, Abrams EJ.

Patient Educ Couns. 2006 Jun;61(3):405-10. Epub 2005 Oct 21.

PMID:
16246515
12.

Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study.

Stone VE, Hogan JW, Schuman P, Rompalo AM, Howard AA, Korkontzelou C, Smith DK; HERS STUDY.

J Acquir Immune Defic Syndr. 2001 Oct 1;28(2):124-31.

PMID:
11588505
13.

Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.

Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA.

J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):386-95.

PMID:
10866231
14.

Adherence to medication regimens among children with human immunodeficiency virus infection.

Reddington C, Cohen J, Baldillo A, Toye M, Smith D, Kneut C, Demaria A, Bertolli J, Hsu HW.

Pediatr Infect Dis J. 2000 Dec;19(12):1148-53.

PMID:
11144374
15.

Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study.

Giacomet V, Albano F, Starace F, de Franciscis A, Giaquinto C, Gattinara GC, Bruzzese E, Gabiano C, Galli L, Viganò A, Caselli D, Guarino A.

Acta Paediatr. 2003 Dec;92(12):1398-402.

PMID:
14971789
16.

Correlates of adherence to antiretroviral therapy in HIV-infected children in Lomé, Togo, West Africa.

Polisset J, Ametonou F, Arrive E, Aho A, Perez F.

AIDS Behav. 2009 Feb;13(1):23-32. doi: 10.1007/s10461-008-9437-6. Epub 2008 Jul 25.

PMID:
18654845
18.

Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.

Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H; Paediatric European Network for Treatment of AIDS Steering Committee.

Pediatr Infect Dis J. 2003 Jan;22(1):56-62.

PMID:
12544410
19.

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Eldred LJ, Wu AW, Chaisson RE, Moore RD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):117-25.

PMID:
9637576
20.

Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study.

Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP.

J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):82-92.

PMID:
11176272

Supplemental Content

Support Center